Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

por Lingvay, Ildiko, Brown‐Frandsen, Kirstine, Colhoun, Helen M., Deanfield, John, Emerson, Scott S., Esbjerg, Sille, Hardt‐Lindberg, Søren, Hovingh, G. Kees, Kahn, Steven E., Kushner, Robert F., Lincoff, A. Michael, Marso, Steven P., Fries, Tea Monk, Plutzky, Jorge, Ryan, Donna H.
Publicado 2022